Rituximab and progressive multi-focal leukoencephalopathy: The jury is deliberating

Leukemia and Lymphoma

Volumn 50, Issue 3, 2009, Pages 323-324

  Carson, Kenneth R ^a   Bennett, Charles L ^b  

^a USA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RITUXIMAB;

B CELL LYMPHOMA; DRUG EXPOSURE; FOLLICULAR LYMPHOMA; HUMAN; JC VIRUS; LARGE CELL LYMPHOMA; LYMPHOMA; NOTE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RADIOIMMUNOTHERAPY; RISK BENEFIT ANALYSIS; STEM CELL TRANSPLANTATION; VIRUS REACTIVATION;

ANTIBODIES, MONOCLONAL; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; RISK ASSESSMENT;

EID: 67649660703     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902779257     Document Type: Note

References (7)

1. Reddy, N., Abel, T. W., Jagasia, M., Morgan, D., Weaver, K. and Greer, J. (2009) Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab. Leuk Lymphoma, 50, pp. 460-462.
2. Hopfinger, G., Plessl, A., Grisold, W., Klimpfinger, M., Hoftberger, R. Reinhart, B. et al. (2008) Progressive multifocal leukoencephalopathy after rituximab in a patient with relapsed follicular lymphoma and low IgG levels and a low CD4 lymphocyte count. Leuk Lymphoma, 49, pp. 2367-2369.
3. Carson, K. R., Evens, A. M., Gordon, L. I., Seymour, J. F., Rosen, S. T. Gottardi-Littell, N. et al. (2008) Rituximab and progressive multifocal leukoencephalopathy: A report of 35 cases. J Clin Oncol (Suppl), 26, p. 8531.
4. Genentech. Rituxan website (2009)
5. Gribben, J. G. (2007) How I treat indolent lymphoma. Blood, 109, pp. 4617-4626.
6. Engsig, F. N., Hansen, A. B., Omland, L. H., Kronborg, G., Gerstoft, J. Laursen, A. L. et al. (2008) Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: A nationwide cohort study. J Infect Dis, 199, pp. 77-83.
7. + T cell activation in mice. Proc Natl Acad Sci USA, 104, pp. 20878-20883.